249 related articles for article (PubMed ID: 32222125)
41. Expanding the living liver donor pool in countries having limited deceased donor activity: Pakistani perspective.
Ullah K; Dogar AW; Rehman IU; Abbas SH; Ullah I; Nisar H; Lee KY
Transpl Immunol; 2022 Dec; 75():101683. PubMed ID: 35952941
[TBL] [Abstract][Full Text] [Related]
42. Liver transplantation: expanding the donor and recipient pool.
Ahmed O; Doyle MBM
Chin Clin Oncol; 2021 Feb; 10(1):6. PubMed ID: 33353363
[TBL] [Abstract][Full Text] [Related]
43. Perioperative complications in liver transplantation using donation after cardiac death grafts: a propensity-matched study.
Pan X; Apinyachon W; Xia W; Hong JC; Busuttil RW; Steadman RH; Xia VW
Liver Transpl; 2014 Jul; 20(7):823-30. PubMed ID: 24711100
[TBL] [Abstract][Full Text] [Related]
44. [Liver transplantation: how to manage organ shortage?].
Pruvot FR; Boleslawski E
Rev Prat; 2009 Mar; 59(3):304-7. PubMed ID: 19408865
[TBL] [Abstract][Full Text] [Related]
45. Liver transplantation for alcoholic liver disease: Lessons learned and unresolved issues.
Ursic-Bedoya J; Faure S; Donnadieu-Rigole H; Pageaux GP
World J Gastroenterol; 2015 Oct; 21(39):10994-1002. PubMed ID: 26494956
[TBL] [Abstract][Full Text] [Related]
46. [Current Status of Deceased Donor Liver Transplantation for Alcoholic Liver Disease in Korea in MELD Era].
Joo DJ
Korean J Gastroenterol; 2021 Jan; 77(1):4-11. PubMed ID: 33495428
[TBL] [Abstract][Full Text] [Related]
47. Expanding the Donor Pool With the Use of Extended Criteria Donation After Circulatory Death Livers.
Mihaylov P; Mangus R; Ekser B; Cabrales A; Timsina L; Fridell J; Lacerda M; Ghabril M; Nephew L; Chalasani N; Kubal CA
Liver Transpl; 2019 Aug; 25(8):1198-1208. PubMed ID: 30929303
[TBL] [Abstract][Full Text] [Related]
48. Liver Transplantation with "Hors Tour" Allocated Versus Standard MELD Allocated Grafts: Single-Center Audit and Impact on the Liver Pool in France.
Azoulay D; Disabato M; Gomez-Gavara C; Feray C; Salloum C; Ngonggang N; Winter A; Hentati H; Levesque E; Lim C; Compagnon P
World J Surg; 2020 Mar; 44(3):912-924. PubMed ID: 31832704
[TBL] [Abstract][Full Text] [Related]
49. Global liver transplantation: emerging trends and ethical challenges.
Hill AL; Khan M; Kiani AZ; Lindemann JD; Vachharajani N; Doyle MB; Chapman WC; Khan AS
Langenbecks Arch Surg; 2023 Oct; 408(1):418. PubMed ID: 37875764
[TBL] [Abstract][Full Text] [Related]
50. Outcomes Using Grafts from Donors after Cardiac Death.
Doyle MB; Collins K; Vachharajani N; Lowell JA; Shenoy S; Nalbantoglu I; Byrnes K; Garonzik-Wang J; Wellen J; Lin Y; Chapman WC
J Am Coll Surg; 2015 Jul; 221(1):142-52. PubMed ID: 26095563
[TBL] [Abstract][Full Text] [Related]
51. Survival Outcomes in Liver Transplantation With Elderly Donors: Analysis of Andalusian Transplant Register.
Cepeda-Franco C; Bernal-Bellido C; Barrera-Pulido L; Álamo-Martínez JM; Ruiz-Matas JH; Suárez-Artacho G; Marín-Gómez LM; Tinoco-González J; Díaz-Aunión C; Padillo-Ruiz FJ; Gómez-Bravo MÁ
Transplant Proc; 2016 Nov; 48(9):2983-2986. PubMed ID: 27932125
[TBL] [Abstract][Full Text] [Related]
52. Liver transplantation of hepatitis B surface antigen positive donors to hepatitis B core antibody recipients: analysis of 27 patients.
Krishnamoorthi R; Manickam P; Cappell MS
Minerva Gastroenterol Dietol; 2014 Jun; 60(2):113-8. PubMed ID: 24780945
[TBL] [Abstract][Full Text] [Related]
53. Adult Liver Allocation in Eurotransplant.
Jochmans I; van Rosmalen M; Pirenne J; Samuel U
Transplantation; 2017 Jul; 101(7):1542-1550. PubMed ID: 28060242
[TBL] [Abstract][Full Text] [Related]
54. Liver transplantation from anti-hepatitis C virus-positive donors: our experience.
Álvaro E; Abradelo M; Fuertes A; Manrique A; Colina F; Alegre C; Calvo J; García M; García-Sesma A; Cambra F; Sanabria R; Moreno E; Jimenez C
Transplant Proc; 2012; 44(6):1475-8. PubMed ID: 22841188
[TBL] [Abstract][Full Text] [Related]
55. How can we utilize livers from advanced aged donors for liver transplantation for hepatitis C?
Uemura T; Nikkel LE; Hollenbeak CS; Ramprasad V; Schaefer E; Kadry Z
Transpl Int; 2012 Jun; 25(6):671-9. PubMed ID: 22487509
[TBL] [Abstract][Full Text] [Related]
56. Liver transplantation for alcoholic hepatitis: update.
Yanny B; Boutros S; Saleh F; Saab S
Curr Opin Gastroenterol; 2020 May; 36(3):157-163. PubMed ID: 32101986
[TBL] [Abstract][Full Text] [Related]
57. Hepatitis C Virus Recurrence Occurs Earlier in Patients Receiving Donation After Circulatory Death Liver Transplant Grafts Compared With Those Receiving Donation After Brainstem Death Grafts.
Townsend SA; Monga MA; Nightingale P; Mutimer D; Elsharkawy AM; Holt A
Transplant Proc; 2017 Nov; 49(9):2129-2134. PubMed ID: 29149973
[TBL] [Abstract][Full Text] [Related]
58. Safe use of liver grafts from hepatitis B surface antigen positive donors in liver transplantation.
Yu S; Yu J; Zhang W; Cheng L; Ye Y; Geng L; Yu Z; Yan S; Wu L; Wang W; Zheng S
J Hepatol; 2014 Oct; 61(4):809-15. PubMed ID: 24824283
[TBL] [Abstract][Full Text] [Related]
59. Why are there so many liver transplants from living donors in Asia and so few in Europe and the US?
Rela M; Rammohan A
J Hepatol; 2021 Oct; 75(4):975-980. PubMed ID: 34111504
[TBL] [Abstract][Full Text] [Related]
60. Decreasing Significance of Early Allograft Dysfunction with Rising Use of Nonconventional Donors.
Ohara S; Macdonough E; Egbert L; Brooks A; Lizaola-Mayo B; Mathur AK; Aqel B; Reddy KS; Jadlowiec CC
Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]